Carina Ittrich

Biberach An Der Riss, BW, Germany

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications

Circulating biomarkers in patients with systemic sclerosis-associated interstitial lung disease in the SENSCIS trial.

Circulating biomarkers in patients with systemic sclerosis-associated interstitial lung disease in the SENSCIS trial.

Journal: Annals of the rheumatic diseases
Published: January 29, 2026

Nailfold capillaroscopy in patients with systemic sclerosis-associated interstitial lung disease: a substudy of the SENSCIS trial.

Nailfold capillaroscopy in patients with systemic sclerosis-associated interstitial lung disease: a substudy of the SENSCIS trial.

Journal: RMD open
Published: March 20, 2025

Circulating biomarkers in subjects with progressive pulmonary fibrosis: data from the INBUILD trial.

Circulating biomarkers in subjects with progressive pulmonary fibrosis: data from the INBUILD trial.

Journal: ERJ open research
Published: February 03, 2025

Peripheral Blood Gene Expression Profiling and Prognostic Significance for the Course of Interstitial Lung Disease in Patients With Systemic Sclerosis.

Peripheral Blood Gene Expression Profiling and Prognostic Significance for the Course of Interstitial Lung Disease in Patients With Systemic Sclerosis.

Journal: Arthritis & rheumatology (Hoboken, N.J.)
Published: September 23, 2024

Effects of nintedanib on circulating biomarkers of idiopathic pulmonary fibrosis.

Effects of nintedanib on circulating biomarkers of idiopathic pulmonary fibrosis.

Journal: ERJ open research
Published: June 19, 2024

Circulating biomarkers and progression of idiopathic pulmonary fibrosis: data from the INMARK trial.

Circulating biomarkers and progression of idiopathic pulmonary fibrosis: data from the INMARK trial.

Journal: ERJ open research
Published: May 22, 2023

An exploratory study investigating biomarkers associated with autoimmune pulmonary alveolar proteinosis (aPAP).

An exploratory study investigating biomarkers associated with autoimmune pulmonary alveolar proteinosis (aPAP).

Journal: Scientific reports
Published: October 12, 2021

Comprehensive analysis of the ErbB receptor family in pediatric nervous system tumors and rhabdomyosarcoma.

Comprehensive analysis of the ErbB receptor family in pediatric nervous system tumors and rhabdomyosarcoma.

Journal: Pediatric blood & cancer
Published: March 31, 2021

FOOTPRINTS study protocol: rationale and methodology of a 3-year longitudinal observational study to phenotype patients with COPD.

FOOTPRINTS study protocol: rationale and methodology of a 3-year longitudinal observational study to phenotype patients with COPD.

Journal: BMJ open
Published: March 23, 2021

Biomarkers of extracellular matrix turnover in patients with idiopathic pulmonary fibrosis given nintedanib (INMARK study): a randomised, placebo-controlled study.

Biomarkers of extracellular matrix turnover in patients with idiopathic pulmonary fibrosis given nintedanib (INMARK study): a randomised, placebo-controlled study.

Journal: The Lancet. Respiratory medicine
Published: March 18, 2019

Influence of field potential duration on spontaneous beating rate of human induced pluripotent stem cell-derived cardiomyocytes: Implications for data analysis and test system selection.

Influence of field potential duration on spontaneous beating rate of human induced pluripotent stem cell-derived cardiomyocytes: Implications for data analysis and test system selection.

Journal: Journal of pharmacological and toxicological methods
Published: June 09, 2016

RNAi Screen for NRF2 Inducers Identifies Targets That Rescue Primary Lung Epithelial Cells from Cigarette Smoke Induced Radical Stress.

RNAi Screen for NRF2 Inducers Identifies Targets That Rescue Primary Lung Epithelial Cells from Cigarette Smoke Induced Radical Stress.

Journal: PloS one
Published: May 23, 2016
Showing 1-12 of 14

Last Updated: 09/26/2026